Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)

The purpose of this funding opportunity is to advance cancer control equity research by stimulating community-engaged, multilevel research interventions that address the impact of social determinants of health on adverse cancer outcomes. Applicants will 1) develop interventions that target the multilevel pathways by which social determinants of health impact adverse cancer outcomes; 2) develop methods, measures, and assess community-level SDOH, community engagement, and cancer control equity processes and outcomes; and 3) build capacity among diverse scholars, stakeholders, and community partners to implement interventions that incorporate the lived experiences of those who face cancer inequities.

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.